Advertisement
Screener

CervoMed Inc. (CRVO) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price

CervoMed Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price

CervoMed Inc. (CRVO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price of $6.28 per share for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-25.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice · last filed 2016-03-25

  • CervoMed Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2015 was $6.28, a 81.52% decline from fiscal 2014.
  • CervoMed Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2014 was $33.99.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 12 month
2015-12-31$6.28
10-K · filed 2016-03-25
2014-12-31$33.99
10-K · filed 2016-03-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
Celularity Inc (CELU)United States$0.038B-0.34
Edesa Biotech, Inc. (EDSA)Canada$0.039B
Actinium Pharmaceuticals, Inc. (ATNM)United States$0.038B2.73
FILANA THERAPEUTICS, INC. (FLNA)United States$0.038B-1.05
PMGC Holdings Inc. (ELAB)United States$0.037B
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98
BriaCell Therapeutics Corp. (BCTX)$0.037B
Seres Therapeutics, Inc. (MCRB)United States$0.036B-3.45
Incannex Healthcare Inc. (IXHL)$0.040B-22.32
MIRA PHARMACEUTICALS, INC. (MIRA)United States$0.036B-4.30